184 related articles for article (PubMed ID: 36044789)
21. B7-H4 expression by nonhematopoietic cells in the tumor microenvironment promotes antitumor immunity.
Rahbar R; Lin A; Ghazarian M; Yau HL; Paramathas S; Lang PA; Schildknecht A; Elford AR; Garcia-Batres C; Martin B; Berman HK; Leong WL; McCready DR; Reedijk M; Done SJ; Miller N; Youngson B; Suh WK; Mak TW; Ohashi PS
Cancer Immunol Res; 2015 Feb; 3(2):184-95. PubMed ID: 25527357
[TBL] [Abstract][Full Text] [Related]
22. Donor and host B7-H4 expression negatively regulates acute graft-versus-host disease lethality.
Saha A; Taylor PA; Lees CJ; Panoskaltsis-Mortari A; Osborn MJ; Feser CJ; Thangavelu G; Melchinger W; Refaeli Y; Hill GR; Munn DH; Murphy WJ; Serody JS; Maillard I; Kreymborg K; van den Brink M; Dong C; Huang S; Zang X; Allison JP; Zeiser R; Blazar BR
JCI Insight; 2019 Oct; 4(19):. PubMed ID: 31578305
[TBL] [Abstract][Full Text] [Related]
23. Exosomal transfer of miR-1238 contributes to temozolomide-resistance in glioblastoma.
Yin J; Zeng A; Zhang Z; Shi Z; Yan W; You Y
EBioMedicine; 2019 Apr; 42():238-251. PubMed ID: 30917935
[TBL] [Abstract][Full Text] [Related]
24. Insulin-like growth factor-1 receptor induces immunosuppression in lung cancer by upregulating B7-H4 expression through the MEK/ERK signaling pathway.
Zhao Z; Zhang N; Li A; Zhou B; Chen Y; Chen S; Huang M; Wu F; Zhang L
Cancer Lett; 2020 Aug; 485():14-26. PubMed ID: 32417396
[TBL] [Abstract][Full Text] [Related]
25. The inhibitory role of b7-h4 in antitumor immunity: association with cancer progression and survival.
He C; Qiao H; Jiang H; Sun X
Clin Dev Immunol; 2011; 2011():695834. PubMed ID: 22013483
[TBL] [Abstract][Full Text] [Related]
26. Upregulation of B7-H4 promotes tumor progression of intrahepatic cholangiocarcinoma.
Xie N; Cai JB; Zhang L; Zhang PF; Shen YH; Yang X; Lu JC; Gao DM; Kang Q; Liu LX; Zhang C; Huang XY; Zou H; Zhang XY; Song ZJ; Sun HX; Fu BM; Ke AW; Shi GM
Cell Death Dis; 2017 Dec; 8(12):3205. PubMed ID: 29235470
[TBL] [Abstract][Full Text] [Related]
27. Exosomal transfer of miR‑25‑3p promotes the proliferation and temozolomide resistance of glioblastoma cells by targeting FBXW7.
Wang J; Li T; Wang B
Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34278448
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of B7-H4 suppresses tumor progression of hepatocellular carcinoma.
Dong L; Xie L; Li M; Dai H; Wang X; Wang P; Zhang Q; Liu W; Hu X; Zhao M
Sci Rep; 2019 Oct; 9(1):14854. PubMed ID: 31619714
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA Expression Profiling of Pancreatic Cancer Cell Line L3.6p1 Following B7-H4 Knockdown.
Qian Y; Feng L; Wu W; Weng T; Hu C; Hong B; Wang FXC; Shen L; Wang Q; Jin X; Yao H
Cell Physiol Biochem; 2017; 44(2):494-504. PubMed ID: 29145206
[TBL] [Abstract][Full Text] [Related]
30. Synergistic effects of host B7-H4 deficiency and gemcitabine treatment on tumor regression and anti-tumor T cell immunity in a mouse model.
Leung J; St-Onge P; Stagg J; Suh WK
Cancer Immunol Immunother; 2017 Apr; 66(4):491-502. PubMed ID: 28074226
[TBL] [Abstract][Full Text] [Related]
31. Clinical significance of the B7-H4 coregulatory molecule as a novel prognostic marker in gastric cancer.
Arigami T; Uenosono Y; Ishigami S; Hagihara T; Haraguchi N; Natsugoe S
World J Surg; 2011 Sep; 35(9):2051-7. PubMed ID: 21748517
[TBL] [Abstract][Full Text] [Related]
32. Enhanced B7-H4 expression in gliomas with low PD-L1 expression identifies super-cold tumors.
Chen D; Li G; Ji C; Lu Q; Qi Y; Tang C; Xiong J; Hu J; Yasar FBA; Zhang Y; Hoon DSB; Yao Y; Zhou L
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32457124
[TBL] [Abstract][Full Text] [Related]
33. A T-cell-engaging B7-H4/CD3-bispecific Fab-scFv Antibody Targets Human Breast Cancer.
Iizuka A; Nonomura C; Ashizawa T; Kondou R; Ohshima K; Sugino T; Mitsuya K; Hayashi N; Nakasu Y; Maruyama K; Yamaguchi K; Akiyama Y
Clin Cancer Res; 2019 May; 25(9):2925-2934. PubMed ID: 30737243
[TBL] [Abstract][Full Text] [Related]
34. Hypoxic Cancer-Secreted Exosomal miR-182-5p Promotes Glioblastoma Angiogenesis by Targeting Kruppel-like Factor 2 and 4.
Li J; Yuan H; Xu H; Zhao H; Xiong N
Mol Cancer Res; 2020 Aug; 18(8):1218-1231. PubMed ID: 32366676
[TBL] [Abstract][Full Text] [Related]
35. A Preclinical Investigation of GBM-N019 as a Potential Inhibitor of Glioblastoma via Exosomal mTOR/CDK6/STAT3 Signaling.
Wu ATH; Huang HS; Wen YT; Lawal B; Mokgautsi N; Huynh TT; Hsiao M; Wei L
Cells; 2021 Sep; 10(9):. PubMed ID: 34572040
[TBL] [Abstract][Full Text] [Related]
36. T7 peptide-decorated exosome-based nanocarrier system for delivery of Galectin-9 siRNA to stimulate macrophage repolarization in glioblastoma.
Li C; Guan N; Liu F
J Neurooncol; 2023 Mar; 162(1):93-108. PubMed ID: 36854924
[TBL] [Abstract][Full Text] [Related]
37. TGF-β1 promotes colorectal cancer immune escape by elevating B7-H3 and B7-H4 via the miR-155/miR-143 axis.
Zhou X; Mao Y; Zhu J; Meng F; Chen Q; Tao L; Li R; Fu F; Liu C; Hu Y; Wang W; Zhang H; Hua D; Chen W; Zhang X
Oncotarget; 2016 Oct; 7(41):67196-67211. PubMed ID: 27626488
[TBL] [Abstract][Full Text] [Related]
38. Unstable B7-H4 cell surface expression and T-cell redirection as a means of cancer therapy.
Iizuka A; Kondou R; Nonomura C; Ashizawa T; Ohshima K; Kusuhara M; Isaka M; Ohde Y; Yamaguchi K; Akiyama Y
Oncol Rep; 2016 Nov; 36(5):2625-2632. PubMed ID: 27632942
[TBL] [Abstract][Full Text] [Related]
39. B7-H3, B7-H4, Foxp3 and IL-2 expression in cervical cancer: Associations with patient outcome and clinical significance.
Huang C; Zhou L; Chang X; Pang X; Zhang H; Zhang S
Oncol Rep; 2016 Apr; 35(4):2183-90. PubMed ID: 26848032
[TBL] [Abstract][Full Text] [Related]
40. Aberrant expression of B7-H4 and B7-H5 contributes to the development of cutaneous squamous cell carcinoma.
Chen L; Zhou B; Tang M; Yao Y; Zhao Y; Hu Y; Lin Y; Ji J; Jiao Q
Arch Dermatol Res; 2024 Jun; 316(7):382. PubMed ID: 38850312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
